U.S. Peripheral Liquid Embolic Agents Market (2026 - 2036)

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation and Scope
                            1.1.1. Product
                            1.1.2. Application
                            1.1.3. End Use
                            1.1.4. Estimates and forecast timeline
                    1.2. Market Definitions
                    1.3. Research Methodology
                    1.4. Information Procurement
                            1.4.1. Purchased Database
                            1.4.2. GVR’s Internal Database
                    1.5. Details of primary research
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                            1.7.1. Commodity flow analysis (Model 1)
                                    1.7.1.1. Approach 1: Commodity flow approach
                            1.7.2. Volume price analysis (Model 2)
                                    1.7.2.1. Approach 2: Volume price analysis
                    1.8. Research Scope and Assumptions
                            1.8.1. List of Secondary Sources
                            1.8.2. List of Primary Sources
                            1.8.3. Objectives

Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                    2.3. Competitive Insights

Chapter 3. U.S. Peripheral Liquid Embolic Agents Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                            3.1.1. Parent Market Outlook
                            3.1.2. Related/Ancillary Market Outlook
                    3.2. Market Dynamics
                            3.2.1. Market Drivers Analysis
                                    3.2.1.1. Rising prevalence of peripheral artery disease and other vascular disorders in the U.S.
                                    3.2.1.2. Increasing adoption of minimally invasive endovascular embolization procedures
                                    3.2.1.3. Increasing cancer burden in the country driving interventional oncology
                                    3.2.1.4. Continuous innovation in liquid embolic technologies
                            3.2.2. Market Restraints Analysis
                                    3.2.2.1. High cost of liquid embolic agents and associated procedure costs
                                    3.2.2.2. Limited reimbursement for selected peripheral embolization procedures
                            3.2.3. Market Opportunity Analysis
                                    3.2.3.1. Expansion of peripheral embolization applications beyond oncology
                                    3.2.3.2. Increasing adoption of embolization in trauma and emergency hemorrhage management
                                    3.2.3.3. Growth in outpatient embolization across ambulatory surgical centers
                                    3.2.3.4. Development of AI-guided and image-guided embolization technologies
                            3.2.4. Market Challenge Analysis
                                    3.2.4.1. Risk of non-target embolization and procedure-related complications
                                    3.2.4.2. Shortage of skilled interventional radiologists and endovascular specialists
                    3.3. U.S. Peripheral Liquid Embolic Agents Market Analysis Tools
                            3.3.1. Porter’s Analysis
                                    3.3.1.1. Bargaining power of the suppliers
                                    3.3.1.2. Bargaining power of the buyers
                                    3.3.1.3. Threats of substitution
                                    3.3.1.4. Threats from new entrants
                                    3.3.1.5. Competitive rivalry
                            3.3.2. PESTEL Analysis
                                    3.3.2.1. Political landscape
                                    3.3.2.2. Economic and Social landscape
                                    3.3.2.3. Technological landscape
                                    3.3.2.4. Environmental landscape
                                    3.3.2.5. Legal landscape

Chapter 4. U.S. Peripheral Liquid Embolic Agents Market: Product Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. U.S. Peripheral Liquid Embolic Agents Market: Product Movement Analysis, 2025 & 2036 (USD Million)
                    4.3. U.S. Peripheral Liquid Embolic Agents Market Size & Trend Analysis, by Product, 2021 to 2036 (USD Million)
                    4.4. Ethylene Vinyl Alcohol Copolymer (EVOH)
                            4.4.1. Ethylene Vinyl Alcohol Copolymer (EVOH) market revenue estimates and forecasts, 2021 - 2036 (USD Million)
                    4.5. Other Embolic Agents
                            4.5.1. Other Embolic Agents market revenue estimates and forecasts, 2021 - 2036 (USD Million)

Chapter 5. U.S. Peripheral Liquid Embolic Agents Market: Application Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. U.S. Peripheral Liquid Embolic Agents Market: Application Movement Analysis, 2025 & 2036 (USD Million)
                    5.3. U.S. Peripheral Liquid Embolic Agents Market Size & Trend Analysis, by Application 2021 to 2036 (USD Million)
                    5.4. Peripheral Vascular Hemorrhage
                            5.4.1. Peripheral Vascular Hemorrhage market revenue estimates and forecasts, 2021 - 2036 (USD Million)
                    5.5. Hypervascular Tumors
                            5.5.1. Hypervascular Tumors market revenue estimates and forecasts, 2021 - 2036 (USD Million)
                    5.6. Peripheral Vascular Malformations / AVMs
                            5.6.1. Peripheral Vascular Malformations/AVMs market revenue estimates and forecasts, 2021 - 2036 (USD Million)
                    5.7. Aneurysms / Pseudoaneurysms
                            5.7.1. Aneurysms / Pseudoaneurysms market revenue estimates and forecasts, 2021 - 2036 (USD Million)
                    5.8. Type II Endoleaks
                            5.8.1. Type II Endoleaks market revenue estimates and forecasts, 2021 - 2036 (USD Million)
                    5.9. Portal Vein Embolization (PVE)
                            5.9.1. Portal Vein Embolization (PVE)market revenue estimates and forecasts, 2021 - 2036 (USD Million)
                    5.10. Venous Applications (varicocele, PCS, varicose veins)
                            5.10.1. Venous Applications (varicocele, PCS, varicose veins) market revenue estimates and forecasts, 2021 - 2036 (USD Million)
                    5.11. Other Peripheral Embolization Applications
                            5.11.1. Other Peripheral Embolization Applications market revenue estimates and forecasts, 2021 - 2036 (USD Million)

Chapter 6. U.S. Peripheral Liquid Embolic Agents Market: End Use Estimates & Trend Analysis
                    6.1. Segment Dashboard
                    6.2. Global U.S. Peripheral Liquid Embolic Agents Market: End Use Movement Analysis, 2025 & 2036 (USD Million)
                    6.3. Global U.S. Peripheral Liquid Embolic Agents Market Size & Trend Analysis, by End Use, 2021 to 2036 (USD Million)
                    6.4. Hospitals & Interventional Radiology (IR) Suites
                            6.4.1. Hospitals & Interventional Radiology (IR) Suites market revenue estimates and forecasts, 2021 - 2036 (USD Million)
                    6.5. Ambulatory Surgical Centers (ASCs)
                            6.5.1. Ambulatory Surgical Centers (ASCs) market revenue estimates and forecasts, 2021 - 2036 (USD Million)
                    6.6. Specialty Clinics / Vascular Centers
                            6.6.1. Specialty Clinics / Vascular Centers market revenue estimates and forecasts, 2021 - 2036 (USD Million)
                    6.7. Others
                            6.7.1. Others market revenue estimates and forecasts, 2021 - 2036 (USD Million)

Chapter 7. Competitive Landscape
                    7.1. Recent Developments & Impact Analysis by Key Market Participants
                    7.2. Company Categorization
                    7.3. Company Market Share Analysis, 2025
                    7.4. Company Heat Map Analysis
                    7.5. Strategy Mapping
                            7.5.1. Expansion
                            7.5.2. Mergers & Acquisition
                            7.5.3. Partnerships & Collaborations
                            7.5.4. New Technology Launches
                            7.5.5. Research And Development
                            7.5.6. Company Profiles
                            7.5.7. Boston Scientific Corporation
                                    7.5.7.1. Company overview
                                    7.5.7.2. Financial performance
                                    7.5.7.3. Product Benchmarking
                                    7.5.7.4. Strategic initiatives
                            7.5.8. Terumo Medical Corporation (MicroVention)
                                    7.5.8.1. Company overview
                                    7.5.8.2. Financial performance
                                    7.5.8.3. Product Benchmarking
                                    7.5.8.4. Strategic initiatives
                            7.5.9. BlackSwan Vascular (Sirtex Medical)
                                    7.5.9.1. Company overview
                                    7.5.9.2. Financial performance
                                    7.5.9.3. Product Benchmarking
                                    7.5.9.4. Strategic initiatives
                            7.5.10. Instylla, Inc.
                                    7.5.10.1. Company overview
                                    7.5.10.2. Financial performance
                                    7.5.10.3. Product Benchmarking
                                    7.5.10.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviation
Table 2 U.S. peripheral liquid embolic agents market, by product, 2021 - 2036 (USD Million)
Table 3 U.S. peripheral liquid embolic agents market, by application, 2021 - 2036 (USD Million)
Table 4 U.S. peripheral liquid embolic agents market, by end use, 2021 - 2036 (USD Million)

List of Figures

Fig. 1 U.S. peripheral liquid embolic agents market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Data analysis models
Fig. 5 Market formulation and validation
Fig. 6 Data validating & publishing
Fig. 7 Market snapshot
Fig. 8 Segment snapshot
Fig. 9 Competitive landscape snapshot
Fig. 10 U.S. peripheral liquid embolic agents market size and growth prospects (USD Million)
Fig. 11 U.S. peripheral liquid embolic agents market: Industry Value Chain Analysis
Fig. 12 U.S. peripheral liquid embolic agents market: Market Dynamics
Fig. 13 U.S. peripheral liquid embolic agents market: PORTER's Analysis
Fig. 14 U.S. peripheral liquid embolic agents market: PESTEL Analysis
Fig. 15 U.S. peripheral liquid embolic agents market share by product, 2025 & 2036 (USD Million)
Fig. 16 U.S. peripheral liquid embolic agents market, by product: market share, 2025 & 2036
Fig. 17 Ethylene Vinyl Alcohol Copolymer (EVOH) market estimates & forecasts, 2021 - 2036 (USD Million)
Fig. 18 Other liquid embolics market estimates & forecasts, 2021 - 2036 (USD Million)
Fig. 19 U.S. peripheral liquid embolic agents market share by application, 2025 & 2036 (USD Million)
Fig. 20 U.S. peripheral liquid embolic agents market, by application: market share, 2025 & 2036
Fig. 21 Peripheral vascular hemorrhage market estimates & forecasts, 2021 - 2036 (USD Million)
Fig. 22 Hypervascular tumors market estimates & forecasts, 2021 - 2036 (USD Million)
Fig. 23 Peripheral vascular malformations / AVMs market estimates & forecasts, 2021 - 2036 (USD Million)
Fig. 24 Aneurysms / pseudoaneurysms market estimates & forecasts, 2021 - 2036 (USD Million)
Fig. 25 Type II endoleaks market estimates & forecasts, 2021 - 2036 (USD Million)
Fig. 26 Portal Vein Embolization (PVE) market estimates & forecasts, 2021 - 2036 (USD Million)
Fig. 27 Venous applications (varicocele, PCS, varicose veins) market estimates & forecasts, 2021 - 2036 (USD Million)
Fig. 28 Other peripheral embolization applications market estimates & forecasts, 2021 - 2036 (USD Million)
Fig. 29 U.S. peripheral liquid embolic agents market share by end use, 2025 & 2036 (USD Million)
Fig. 30 U.S. peripheral liquid embolic agents market, by end use: market share, 2025 & 2036
Fig. 31 Hospitals & Interventional Radiology (IR) suites market estimates & forecasts, 2021 - 2036 (USD Million)
Fig. 32 Ambulatory Surgical Centers (ASCs) market estimates & forecasts, 2021 - 2036 (USD Million)
Fig. 33 Specialty clinics / vascular centers market estimates & forecasts, 2021 - 2036 (USD Million)
Fig. 34 Others market estimates & forecasts, 2021 - 2036 (USD Million)
Fig. 35 Key company categorization
Fig. 36 Company market positioning
Fig. 37 Key company market share analysis, 2025
Fig. 38 Strategic framework